Sex Selection Moves to Consumer Culture
By Marcy Darnovsky,
Genetic Crossroads
| 08. 20. 2003
Ads for "Family Balancing" in The New York Times
Several times over the past few months, a small
but striking ad from a Virginia-based fertility clinic has appeared
in the Sunday Styles section of The New York Times. Alongside
a smiling baby, its boldface headline asks, "Do You Want
To Choose the Gender Of Your Next Baby?"
If so, the ad continues, you can join "prospective parents…from
all over the world" who come to the Genetics & IVF
Institute (GIVF) for an "exclusive scientifically-based
sperm sorting gender selection procedure." The technique,
known by the trademarked name MicroSort, is offered as a way
to choose a girl or boy either for the "prevention of genetic
diseases" (selecting against the sex affected by an X-linked
or Y-linked condition) or for "family balancing" (selecting
for a girl in a family that already has one or more boys, or
vice versa).
GIVF
has been promoting MicroSort on its website for several years,
and a few other fertility clinics offer other "family balancing"
methods online. But the MicroSort ads in The New York Times
represent a bolder and higher-profile approach. They mark the...
Related Articles
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
The title of this book is clever, not least because it is borrowed from a very secret society of a dozen Stanford students. Theo Baker, a gregarious computer science freshman, was interviewed by the hyper-rich anonymous entrepreneur who quietly assembled the members. The unspoken suggestion was that he might consider hiring some of the members in service of acquiring his next billion. (Either Baker was not offered a place or he is not admitting it.) Such are the ways of...
By Jan Grue, Boston Review | 06.17.2026
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...